Synced daily from ClinicalTrials.gov via AACT. Last sync: .
18 Obicetrapib clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 9 indications (including High Cholesterol & Hypercholesterolemia) and 14,305 total planned enrollment. 6 Phase 3 Obicetrapib trials and 7 Phase 2 are listed. 3 Obicetrapib clinical trials are actively recruiting at 22 U.S. sites across 14 states. Most recent activity: NCT07219602 (Jun 2028).
Where to Participate: All Obicetrapib Trial Sites in the U.S. (22 sites across 14 states)
Every actively recruiting Obicetrapibtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
RUBENSA Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
18 Obicetrapib clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 3 are actively recruiting participants. 12 are marked completed.
Are Obicetrapib clinical trials recruiting in 2026?
Yes — 3 Obicetrapib trials are actively recruiting in 2026, with 22 U.S. sites across 14 states. See the recruiting trials and the per-state site list further down this page.
What conditions is Obicetrapib being studied for?
Obicetrapib is being studied for High Cholesterol, Hypercholesterolemia, Dyslipidemias, Healthy Volunteers, Familial Hypercholesterolemia and 18 more. The trials are grouped by indication on this page.
What phase is Obicetrapib in?
Obicetrapib clinical trials span 6 Phase 3, 7 Phase 2, 5 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Obicetrapib clinical trials?
The lead sponsor across the most Obicetrapib trials is NewAmsterdam Pharma. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Obicetrapibas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.